Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Japanese Drug Store Chain Sugi Holdings Acquires TMRC’s CRO Business

This article was originally published in PharmAsia News

Executive Summary

Japan drug store chain Sugi Holdings will acquire Tokyo-based bioventure company TMRC's contract clinical research business. The two agreed March 16 that TMRC will spin off the CRO business to form TMRC CRO by March 31, and Sugi's wholly owned CRO business wing Sugi Medical will acquire 100 percent of Tmrc CRO shares. Sugi Holdings subsidiary Sugi Medical Research is also scheduled to join the merged company June 1. Sugi Medical expanded into the CRO business in Japan through acquiring Fuji Biomedics's CRO section last year. (Click here for more - Japanese language
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC071136

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel